4.7 Article

Growth Standards of Infants With Prader-Willi Syndrome

Journal

PEDIATRICS
Volume 127, Issue 4, Pages 687-695

Publisher

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2010-2736

Keywords

Prader-Willi syndrome; standardized growth curves; obesity; growth hormone therapy

Categories

Funding

  1. NIH, from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD061222]
  2. NIH Office of Rare Diseases Research [RR019478]

Ask authors/readers for more resources

OBJECTIVE: To generate and report standardized growth curves for weight, length, head circumference, weight/length, and BMI for nongrowth hormone-treated white infants (boys and girls) with Prader-Willi syndrome (PWS) between 0 and 36 months of age. The goal was to monitor growth and compare data with other infants with PWS. METHODS: Anthropometric measures (N = 758) were obtained according to standard methods and analyzed from 186 non-growth hormone-treated white infants (108 boys and 78 girls) with PWS between 0 and 36 months of age. Standardized growth curves were developed and the 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles were calculated by using the LMS (refers to lambda, mu, and sigma) smoothing procedure method for weight, length, head circumference, weight/length, and BMI along with the normative 50th percentile using Centers for Disease Control and Prevention national growth data from 2003. The data were plotted for comparison purposes. RESULTS: Five separate standardized growth curves (weight, length, head circumference, weight/length, and BMI) representing 7 percentile ranges were developed from 186 non-growth hormone-treated white male and female infants with PWS aged 0 to 36 months, and the normative 50th percentile was plotted on each standardized infant growth curve. CONCLUSIONS: We encourage the use of these growth standards when examining infants with PWS and evaluating growth for comparison purposes, monitoring for growth patterns, nutritional assessment, and recording responses to growth hormone therapy, commonly used in infants and children with PWS. Pediatrics 2011; 127:687-695

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available